Effect of danazol on coagulation parameters and bleeding in hemophilia

Harinder S. Garewal, H S Garewal, J J Corrigan, B G Durie, M A Jeter, M L Damiano
JAMA: The Journal of the American Medical Association · 1985 · vol. 253(8) , pp. 1154 · doi:10.1001/jama.1985.03350320078021 · PMID:3968845 · W2056512700
Other OA: closed CC0 ⤵ 6 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-13 ⓘ

Danazol treatment in hemophiliacs shortened APTT but increased bleeding, possibly due to enhanced fibrinolytic activity, and did not consistently elevate factor activity.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Danazol was given orally at a dose of 600 mg/day to six hemophiliacs for eight to 14 weeks. All patients showed a significant decrease in activated partial thromboplastin time (APTT) beginning with the first measurement (two weeks) and persisting until use of the drug was discontinued. However, a corresponding increase in the deficient factor activity could not be consistently demonstrated. Despite the shortened APTT, bleeding episodes continued in the severe hemophiliacs and the patient with Christmas disease. In four patients, bleeding appeared to increase in severity or change in pattern, and in two cases the bleeding manifestations did not respond to usual factor infusions but responded to discontinuation of the drug therapy and further factor replacement. Euglobulin lysis times were measured in five patients (one hemophiliac and four with nonhemophilic conditions) who were receiving danazol. The lysis times were markedly shortened. Increased fibrinolytic activity may be responsible for the increased bleeding manifestations in danazol-treated hemophiliacs.

My notes (saved in your browser only)

MeSH descriptors

Blood Coagulation Blood Coagulation Factors Danazol Hemophilia A Pregnadienes Adult Blood Coagulation Blood Coagulation Factors Danazol Hemophilia A Hemophilia A Hemophilia A Hemophilia B Hemophilia B Hemophilia B Hemophilia B Humans Male Partial Thromboplastin Time Pregnadienes

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (11)

Cited by (6)

Source provenance

openalex
last seen: 2026-05-11T04:51:27.821502+00:00
pubmed
last seen: 2026-10-08T21:47:11.652989+00:00
unpaywall
last seen: 2026-10-15T06:24:24.424788+00:00
License: CC0 · commercial use OK